{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-26-002721","form_type":"8-K","ticker":"REPL","cik":"0001737953","company_name":"Replimune Group, Inc.","filed_at":"2026-01-12T23:59:59+00:00","discovered_at":"2026-05-14T18:02:36.037641+00:00","generated_at":"2026-05-16T10:54:21.448429+00:00","sec_items":["7.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.45,"calibrated_materiality_score":0.45,"confidence":"low","headline":"Replimune files updated corporate presentation for J.P. Morgan; exhibit content not available","bullets":["Company released updated corporate presentation on January 12, 2026.","Presentation to be presented at 44th Annual J.P. Morgan Healthcare Conference on January 14, 2026.","Presentation covers recent business developments and clinical data for RP1 and RP2 programs.","Exhibit 99.1 text was not provided, preventing detailed analysis of clinical or strategic updates.","No specific financial or clinical figures were disclosed in the 8-K filing."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-26-002721","json":"https://secwatch.observer/filing/0001104659-26-002721.json","markdown":"https://secwatch.observer/filing/0001104659-26-002721.md","text":"https://secwatch.observer/filing/0001104659-26-002721.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737953/000110465926002721/0001104659-26-002721-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737953/000110465926002721/tm262890d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-16T10:54:21.448429+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}